GS-9876
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GS-9876, covering 2018-09-19 to 2018-09-19. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability, and Efficacy of GS-9876 in Participants With Active Rheumatoid Arthritis on Background Therapy With Methotrexate [Phase 2]